{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:45:59Z","timestamp":1791931559927,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001030","name":"Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.diabres.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T08:54:40Z","timestamp":1466672080000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: An examination of the Kraft database"],"prefix":"10.1016","volume":"118","author":[{"given":"Catherine","family":"Crofts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.diabres.2016.06.007_b0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15562\/diabesity.2015.19","article-title":"Hyperinsulinaemia: a unifying theory of chronic disease?","volume":"1","author":"Crofts","year":"2015","journal-title":"Diabesity"},{"issue":"2","key":"10.1016\/j.diabres.2016.06.007_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.surg.2014.04.028","article-title":"Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think","volume":"156","author":"Kelly","year":"2014","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.diabres.2016.06.007_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5694\/j.1326-5377.2006.tb00506.x","article-title":"Insulin levels in insulin resistance: phantom of the metabolic opera?","volume":"185","author":"Samaras","year":"2006","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.diabres.2016.06.007_b0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/diacare.13.6.631","article-title":"Insulin and atheroma: 20-yr perspective","volume":"13","author":"Stout","year":"1990","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2016.06.007_b0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.diabres.2016.06.007_b0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/ern.09.18","article-title":"Metabolic links between diabetes and Alzheimer\u2019s disease","volume":"9","author":"Maher","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.diabres.2016.06.007_b0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpendmet0366","article-title":"Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes","volume":"3","author":"Rask-Madsen","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.diabres.2016.06.007_b0040","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/01.CCM.0000186787.64500.12","article-title":"Reactive oxygen species","volume":"33","author":"Bayir","year":"2005","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.diabres.2016.06.007_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.diabres.2016.06.007_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.12363","article-title":"Insulin and IGF1 modulate turnover of polysialylated neuronal cell adhesion molecule (PSA-NCAM) in a process involving specific extracellular matrix components","author":"Monzo","year":"2013","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.diabres.2016.06.007_b0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-\u03b2 peptide in Alzheimer\u2019s disease: Review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"8","key":"10.1016\/j.diabres.2016.06.007_b0060","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2337\/dc09-0153","article-title":"Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report","volume":"32","author":"Dankner","year":"2009","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2016.06.007_b0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmet.2012.10.019","article-title":"Hyperinsulinemia drives diet-induced obesity independently of brain insulin production","volume":"16","author":"Mehran","year":"2012","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.diabres.2016.06.007_b0070","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1001\/jama.2014.4133","article-title":"Increasing adiposity: consequence or cause of overeating","volume":"311","author":"Ludwig","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2016.06.007_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2410","article-title":"Hepatic manifestations of metabolic syndrome","author":"Medina-Santill\u00e1n","year":"2013","journal-title":"Diabetes\/Metab Res Rev"},{"issue":"4","key":"10.1016\/j.diabres.2016.06.007_b0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/45.4.561","article-title":"Within- and between-subject variation in commonly measured anthropometric and biochemical variables","volume":"45","author":"Widjaja","year":"1999","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.diabres.2016.06.007_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/labmed\/6.2.10","article-title":"Detection of diabetes mellitus in situ (occult diabetes)","volume":"6","author":"Kraft","year":"1975","journal-title":"Lab Med"},{"key":"10.1016\/j.diabres.2016.06.007_b0090","series-title":"Diabetes epidemic and you","author":"Kraft","year":"2011"},{"issue":"1","key":"10.1016\/j.diabres.2016.06.007_b0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/23.1.131","article-title":"Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974)","volume":"23","author":"Passey","year":"1977","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2016.06.007_b0100","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications","author":"World Health Organization","year":"1999"},{"issue":"3","key":"10.1016\/j.diabres.2016.06.007_b0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diacare.24.3.460","article-title":"Diagnosing insulin resistance in the general population","volume":"24","author":"McAuley","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2016.06.007_b0110","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1038\/nutd.2014.5","article-title":"The influence of fasting insulin level in post-gestational diabetes mellitus women receiving low-glycaemic-index diets","volume":"4","author":"Ghani","year":"2014","journal-title":"Nutr Diab"},{"issue":"9","key":"10.1016\/j.diabres.2016.06.007_b0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a116768","article-title":"How good a marker is insulin level for insulin resistance?","volume":"137","author":"Laakso","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.diabres.2016.06.007_b0120","series-title":"Radioassay: Clinical concepts","article-title":"Glucose\/insulin tolerance. A routine clinical laboratory tool enhancing diabetic detection","author":"Kraft","year":"1974"},{"issue":"suppl 3","key":"10.1016\/j.diabres.2016.06.007_b0125","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2016.06.007_b0130","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/dc12-0246","article-title":"Patterns of insulin concentration during the OGTT predict the risk of type 2 diabetes in Japanese Americans","volume":"36","author":"Hayashi","year":"2013","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2016.06.007_b0135","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1101\/gad.1550907","article-title":"Mechanisms of obesity-associated insulin resistance: many choices on the menu","volume":"21","author":"Qatanani","year":"2007","journal-title":"Genes Dev"},{"issue":"8","key":"10.1016\/j.diabres.2016.06.007_b0140","first-page":"1341","article-title":"Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children","volume":"46","author":"Odeleye","year":"1997","journal-title":"Diabetes \u2013 Am Diab Assoc"},{"issue":"1","key":"10.1016\/j.diabres.2016.06.007_b0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1475-2840-11-76","article-title":"Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range","volume":"11","author":"Ning","year":"2012","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2016.06.007_b0150","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the veterans administration genetic epidemiology study","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2016.06.007_b0155","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.diabres.2011.08.025","article-title":"Reproducibility of multiple repeated oral glucose tolerance tests","volume":"94","author":"Gordon","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2016.06.007_b0160","series-title":"Prevalence of overweight, obesity and extreme obesity among adults: United States, trends 1960\u20131962 through 2007\u20132008","author":"Ogden","year":"2010"},{"key":"10.1016\/j.diabres.2016.06.007_b0165","unstructured":"Centers for Disease Control and Prevention. Number (in millions) of civilian, noninstitutionalized persons with diagnosed diabetes, United States, 1980\u20132011. 2013 [cited 2015 28 April]; Available from: http:\/\/www.cdc.gov\/diabetes\/statistics\/prev\/national\/figpersons.htm."},{"issue":"1","key":"10.1016\/j.diabres.2016.06.007_b0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jada.2007.10.003","article-title":"Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis","volume":"108","author":"Kirk","year":"2008","journal-title":"J Am Diet Assoc"},{"issue":"1","key":"10.1016\/j.diabres.2016.06.007_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","article-title":"Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base","volume":"31","author":"Feinman","year":"2015","journal-title":"Nutrition"},{"issue":"11","key":"10.1016\/j.diabres.2016.06.007_b0180","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI11705","article-title":"Unraveling the mechanism of action of thiazolidinediones","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2016.06.007_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2013.04.004","article-title":"AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a \u201cglycoxidation-centric\u201d point of view","author":"Chilelli","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.diabres.2016.06.007_b9000","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/clinchem\/25.10.1844","article-title":"Evaluation of the BMC glucose oxidase\/peroxidase-4-aminophenazone-phenol procedure for glucose as adapted to the Technicon SMAC","volume":"25","author":"Purcell","year":"1979","journal-title":"Clin Chem"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716301577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716301577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T15:49:26Z","timestamp":1600789766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822716301577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":38,"alternative-id":["S0168822716301577"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2016.06.007","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: An examination of the Kraft database","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}